These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 1469781
1. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2]. Nakagawa K, Tsuji H, Yamada K, Yamada Y, Masuda H, Yamagami M, Yoneda M, Takada O, Sawada S, Kitani T. Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781 [Abstract] [Full Text] [Related]
2. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases]. Kawai Y, Shiomi T, Ono H, Katagiri H, Uchida R, Sugisaki N, Watanabe K. Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284 [Abstract] [Full Text] [Related]
4. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate]. Suzuki T, Amano K, Kuroso K, Fukutake K, Fujimaki M. Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024 [Abstract] [Full Text] [Related]
5. Activation of the coagulation cascade in patients with leptospirosis. Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, Opartkiattikul N, White NJ, Peacock SJ, Day NP. Clin Infect Dis; 2008 Jan 15; 46(2):254-60. PubMed ID: 18171258 [Abstract] [Full Text] [Related]
6. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency. Ingerslev J, Holm M, Christiansen K, Knudsen L, Négrier C. Blood Coagul Fibrinolysis; 1998 Mar 15; 9 Suppl 1():S129-34. PubMed ID: 9819044 [Abstract] [Full Text] [Related]
7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S. Rinsho Byori; 2004 Apr 15; 52(4):355-61. PubMed ID: 15164605 [Abstract] [Full Text] [Related]
9. Elevated prothrombin fragment 1 + 2 (F1 + 2) plasma levels may provide evidence of hypercoagulable states in gynecologic emergencies. Anand A. Gynecol Oncol; 1994 Jul 15; 54(1):101. PubMed ID: 8020831 [No Abstract] [Full Text] [Related]
10. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer. Gadducci A, Marrai R, Baicchi U, Gagetti O, Facchini V, Genazzani AR. Gynecol Oncol; 1996 May 15; 61(2):215-7. PubMed ID: 8626135 [Abstract] [Full Text] [Related]
12. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke. Soncini M, Gasparini P, Lorena M, Motta A, Cimminiello C. Minerva Cardioangiol; 2000 Nov 15; 48(11):349-56. PubMed ID: 11214426 [Abstract] [Full Text] [Related]
15. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial. Christersson C, Oldgren J, Bylock A, Siegbahn A, Wallentin L. Eur Heart J; 2007 Mar 15; 28(6):692-8. PubMed ID: 17314111 [Abstract] [Full Text] [Related]
18. [Clinical application of laboratory diagnosis: leukemia and DIC]. Deguchi K, Zhao LJ, Shirakawa S. Rinsho Byori; 1991 Jul 15; 39(7):736-42. PubMed ID: 1833571 [Abstract] [Full Text] [Related]
19. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E. Rinsho Byori; 1991 Mar 15; 39(3):309-14. PubMed ID: 1828842 [Abstract] [Full Text] [Related]